RG7155 potently inhibited the viability of CSF-1-differentiated macrophages in vitro and reduced the number of CD68+ CD163+ TAMs in tumor biopsies from diffuse-type giant cell tumor patients [332]. The gene discussed is CD163; the disease is neoplasm.